A Prospective study of Role of Minimally Invasive Approaches for Renal Salvagibility in management of Emphysematous  Pyelonephritis by Saraswathi, S
 
 
A  PROSPECTIVE  STUDY OF ROLE OF MINIMALLY 
INVASIVE APPROACHES FOR RENAL SALVAGIBILITY IN 
MANAGEMENT OF  EMPHYSEMATOUS PYELONEPHRITIS 
 
Dissertation submitted in partial fulfillment of the requirements of 
 
M.Ch DEGREE EXAMINATION 
 
BRANCH 1V – UROLOGY 
 
 GOVERNMENT   KILPAUK   MEDICAL   COLLEGE & HOSPITAL  
CHENNAI - 600010 
 
 
THE   TAMILNADU  DR.M.G.R  MEDICAL  UNIVERSITY 
CHENNAI  -  600 032. 
AUGUST   2015 
 
 
CERTIFICATE 
This is to certify that this dissertation entitled “A  Prospective  Study of 
Role of minimally invasive approaches for renal salvagibility in management 
of  Emphysematous Pyelonephritis” is the bonafide work done by                                  
Dr. S. Saraswathi, under our direct guidance and supervision in the Department of 
Urology, Kilpauk  Medical College Hospital & Govt. Royapettah hospital, 
Chennai,, in fulfilment of regulations of the Tamil Nadu Dr. M.G.R. Medical 
University for the award of M.Ch Higher Speciality degree, Branch IV – 
Urology during this period of study from December  2012 – November  2014. 
 
 
Prof. N. Muthulatha, MS., MCh.,  Prof. K. Saravanan , MS., MCh,, 
Head of the Department     Professor, 
Department of Urology,    Department of Urology, 
Kilpauk Medical College,   Govt.  Royapettah  Hospital, 
Chennai – 600010.     Chennai – 600013. 
 
Date :  
Place : Chennai 
 
Dr. R.Narayanababu, MD., DCH., 
The Dean, 
Kilpauk Medical College and Hospital, Chennai – 600010 
 
 
 
 
CERTIFICATE BY THE GUIDE 
 
This is to certify that this dissertation entitled “A  Prospective  Study of 
Role of minimally invasive approaches for renal salvagibility in management 
of  Emphysematous Pyelonephritis” submitted by  Dr. S. Saraswathi  appearing 
for M.Ch UROLOGY degree examination in August 2015 is an original bonafide 
record of work done by him during the academic period of August 2012 to July 
2015 under my guidance and supervision in partial fulfillment of requirement of 
the Tamil Nadu Dr. M.G.R. Medical University, Chennai. I forward this to the 
Tamil Nadu Dr. M.G.R. Medical University, Chennai, Tamil Nadu, India.  
.   
 
            Prof. R. Govindharajan, MS.,MCh., 
                                                                 Professor   of   Urology, 
                                                                 Department of  Urology, 
                                                           Kilpauk Medical College Hospital, 
                                                             Chennai – 600 010.  
 
 
 
 
 
DECLARATION BY THE CANDIDATE  
 
I, Dr. S. Saraswathi , solemnly  declare that this dissertation titled   entitled  
“A  Prospective  Study of Role of minimally invasive approaches for renal 
salvagibility in management of  Emphysematous Pyelonephritis” was done by 
me in the Department of Urology, Kilpauk  Medical  College  Hospital  and   
Government  Royapettah  Hospital,  Chennai   under   the     guidance    and    
supervision     of    Prof. Dr. R. Govindharajan, M.S., M.Ch.,  Professor  of   
Urology, Kilpauk   Medical College  Hospital. 
This dissertation is submitted to the Tamil Nadu Dr.M.G.R. Medical 
University, Chennai-600032 in partial fulfilment of the University requirements for 
the award of the degree of M.Ch., Urology. 
 
Place : Chennai 
Date  :  
(Dr.S. Saraswathi)  
 
 
 
 
ACKNOWLEDGEMENT 
I owe   my   thanks   to   Prof. Dr. NARAYANABABU MD., DCH.,  the  
Dean,  Kilpauk   Medical   College,  Chennai,  for permitting   me   to   utilize  the   
facilities  and conducting  this  study. I sincerely thank the members of   Ethical   
Committee   for approving this study. 
I am extremely   grateful   to Prof. Dr. MUTHULATHA.N, M.S, M.Ch., 
Professor   of   Urology  and   Head  of  the  Department,  Department   of    
Urology, Kilpauk   Medical  College   and  Hospital, Chennai-10, for   his    
encouragement  and  permission  for  granting  unrestricted  access  to utilising  the  
resources  of  the Department. 
I am extremely thankful to Prof. Dr. K.SARAVANAN, M.S.,M.Ch., 
Professor  of   Urology,  Government   Royapettah   Hospital  and  my   guide,   for   
devising   this   study, valuable   guidance,   motivation, expert  advice   and   help   
rendered   during  this  study. 
I am extremely thankful to Prof. Dr.V. Ilangovan, M.S., M.Ch.,                       
Prof. Dr. R. Govindharajan, M.S., M.Ch.,  Department of   Urology, Kilpauk  
Medical  College  for  their   constant  encouragement, valuable   guidance,  
motivation, expert advice   and   help  rendered   during   the  procedures  and  
throughout this  study. 
 
 
I also extend   my sincere   thanks to all  Assistant Professors   of    our  
department    Dr. P. LEELA KRISHNA, M.Ch., Dr. R. JAYAGANESH, 
M.Ch.,  Dr. A. SENTHILVEL, M.Ch., and Dr. D. JASON PHILLIP., M.Ch.,  
Dr. EZHILSUNDER M.Ch., for helping me with their time and advice during 
this study. 
I extend my thanks to my colleagues in my department for their valuable   
help. 
I extend my thanks to  Dr. Arun vijayan, MD.,DIH., Department of SPM, 
Kilpauk Medical College  statistician for his help in statistics of this study 
The blessings of God with out which this work would not have been  
possible.  
Im am extremely grateful to all the patients who have participated in this 
study 
I thank my family for their kind cooperation 
 
 
  
 
 
TABLE OF CONTENTS 
 
S.NO TITLE PAGE NO. 
1 INTRODUCTION 1 
2 AIMS AND OBJECTIVES 3 
3 REVIEW OF LITERATURE  
4 
4 MATERIALS AND METHODS 22 
5 RESULTS 29 
6 DISCUSSION 68 
7 SUMMARY 74 
8 CONCLUSION 76 
9 BIBILIOGRAPHY 82 
10 ANNEXURES 91 
 
ABBREVIATIONS 
 
DM - Diabetes mellitus 
UTI    - Urinary tract infection 
EPN    - Emphysematous pyelonephritis 
E.coli    -  Escherichia coli 
K.pneumoniae  - Klebsiella pneumoniae 
B.fragilis   - Bacteroides fragilis 
ATP    - Adenosine tri phosphate 
NAD    - Nicotinamide adenine dinucleotide 
USG    - Ultrasonogram 
CT scan   - Computerised Tomographic scan 
IVU    - Intravenous urogram 
SD    - Standard deviation 
TC    - Total count 
Hb    - Haemoglobin 
PCD    - Percutaneous drainage 
PCN    - Percutaneous nephrostomy 
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INTRODUCTION 
                      
Emphysematous pyelonephritis  was first coined by Schultz and Klorfein 
2 and is applied when  gas is formed and collected only in or around the kidney3. 
Emphysematous pyelonephritis was reported earlier by Kelly and MacCallum in 
18981 and was considered to be rare. It has got multiple terminologies, such as 
renal emphysema, pneumonephritis, pyelonephritis, emphysematosa  and  
pneumonephrogram. As pointed by Schultz and Klorfein, emphysematous 
pyelonephritis is the preferred designation4.  
Necrotizing lesions in infected tissue in diabetic patients or those with an 
obstructive urinary tract infection by Gas-forming bacteria which uses glucose 
as a substrate is EPN. Complication of  acute sepsis  results in a poor prognosis. 
This  disease creats an  urologic emergency5. Mortality with Emphysematous 
pyelonephritis vary from 7 to 75% 6,7 . It needs special attention  because of its 
life-threatening potential. 
Though  it has generally been regarded as a rare infection, with the more 
extensive use of ultrasonography and computed tomography in the evaluation of 
patients  with features of sepsis or complicated urinary tract infection (UTI), 
more cases of Emphysematous pyelonephritis (EPN) are being recognized. 
Huang et al believed that EPN is not rare and should be considered an important 
clinical entity 8. 
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Earlier days, emphysematous pyelonephritis was managed by  
nephrectomy or open surgical drainage and appropriate antibiotics6. 
Fluoroscopic guided percutaneous drainage for the treatment of emphysematous 
pyelonephritis was first described by Hudson et al 9. With the advent of image 
guided drainage procedures and endoscopic drainage procedures - PCD, 
endoscopic stenting  and medical therapy consisting of intravenous antibiotics 
and glycemic control measures  are often applied. This is a disease that most 
commonly affects diabetics- a systemic disease with proven hazardous effect 
over the other uninvolved kidney in the long run. Moreover emphysematous 
pyelonephritis can be a bilateral problem in 10%10 and can affect solitary 
kidneys. Renal conservation becomes more preferable in more instances. 
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AIMS AND OBJECTIVES 
 
 
1. To study the possibility of renal salvagibility by minimally invasive   
approaches in emphysematous pyelonephritis. 
 
2. To analyse the prognostic factors that favours renal salvagibility in 
emphysematous pyelonephritis  
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REVIEW OF LITERATURE 
 
 
Definition: 
                  
Emphysematous pyelonephritis is defined as a severe acute bacterial 
infection of the kidney characterized by the presence of gas within the renal 
parenchyma, collecting system or perinephric tissue 11.  
Some investigators referred the term emphysematous pyelonephritis is  
renal parenchymal infection, whereas most prefer to include both conditions of 
renal parenchyma and perinephric tissues under the same designation6. The 
definition that is  accepted is the possible manifestations of gas-forming acute 
renal infections 8. 
Sites: 
Emphysematous pyelonephritis develops  in the following sites of urinary 
tracts: 
1. Emphysematous nephritis -  involvement of  renal parenchyma 
2. Emphysematous pyelitis –  gas in calyx and pelvis 
3. Emphysematous ureteritis –  collection of gas in ureter 
4. Emphysematous cystitis – gas in urinary bladder 12. 
Etiology: 
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Emphysematous pyelonephritis exclusively occurs in diabetic patients, in 
patients not with  DM it is due to obstruction of the  reno ureteral sysyem 
8,11,13,12. 
As stated  by Gillies and Flocks in 1941, three factors that are essential 
for gas formation are: 
1. Urinary tract obstruction 
2. Uncontrolled diabetes mellitus 11 
3. Gas producing organisms  6 
4. Defective immune system  6,14 . 
Causative organisms: 
EPN is caused by an organisms  that are normal habitants of  urinary and 
gastrointestinal tracts. Based on the study by Michaeli et al 6, Escherichia coli 
was the most common organism (71%). In 19% of the cases >1 organism was 
present.  Aerobacter aerogenes and Proteus mirabilis were isolated in some 
patients. Anaerobic bacteria were grown rarely 6.     
According to Huang et al, pathogens was identified in 98% of cases. 
E.coli was the commonest organism isolated (69%), K.pneumoniae was the 
second (31%).  6% had E.coli infection along with Streptococcus spp. or 
Proteus spp. Anaerobic organisms were not obtained 8.Thus the most common 
organism grown is E.coli followed by Klebsiella. Proteus, Pseudomonas, 
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Aerobacter aerogenes, Streptococcus and rarely anaerobes, Candida albicans 
and Cryptococcus may be grown15.  
 
Role of diabetes mellitus: 
                   
Diabetic patients are immune compromised hosts and they have 
susceptibility for bacterial infection 14. EPN most commonly occurs in diabetics. 
Diabetes mellitus was present in 87% of the emphysematous patients according 
to Michaeli et al. High tissue glucose levels acts as source for the organisms to 
produce carbon dioxide and hydrogen via the fermentation of sugar6. EPN is 
found exclusively in uncontrolled diabetics, still  reported in non diabetics and 
diabetics with excellent diabetes control. In the non diabetic patients, disease is 
less extensive and is almost always associated with obstruction of reno ureteral 
unit 6.  
The role of obstruction 
Obstruction was present only in 40% of patients of EPN, Michaeli et al 
refutes the notion gas formation needs obstruction. Mostly, bilateral EPN and 
EPN in solitary kidneys had urinary tract obstruction. EPN nearly always is 
associated with ureteral obstruction in non-diabetics6. In Huang et al’s study, 
22% of diabetics and all the non diabetics (2 patients) had associated urinary 
tract obstruction. Left kidney than the right one more frequently is affected by 
urinary tract obstruction (64% vs 36%)8. 
Pathophysiology 
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It is said that hyperglycemia  is source  for the organisms to produce CO2 
and hydrogen via the fermentation of sugar 6.  
Two important features found commonly in EPN are necrotizing 
infection and compromised vascular supply shown by presence if thrombus in 
intra renal vessels and renal infarctions. Theory of  Schainuck and associates 
supports these findings16,14 emphasizing the importance of impaired tissue and 
vascular response. Obstruction and diabetic glomerulopathy are local factors 
and systemic factors such as increased risk of infectious complications 
associated with diabetes mellitus are all said to be responsible for tissue and 
vascular damage. Host response that predisposes to tissue damage is the 
impaired immune response, not the hyperglycemia.. The impaired host response 
theory is probable explanation for the presence of EPN in patients without 
diabetes and also in those without evidence of infection. In patients with 
diabetes mellitus and EPN both mechanisms (sugar fermentation and defective 
host response) coexists and explain the origin of profuse gas production6. 
 
Cause  of Gas Formation 
 
 
Metabolic energy is required in a constant manner by the growing 
organism. Fermentation proceeds via the glycolytic (Embden-Meyerhof) 
pathway, in which two molecules of adenosine triphosphate (ATP) are 
produced. Pyruvate is generated during the process of conversion of NAD+ to 
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NADH as end product. Apart from this several other pathways  have been 
evolved in the microorganism for the reoxidation of NADH by pyruvate or its 
derivative such as lactic fermentation (streptococcus, lactobacillus), 
fermentation of alcohol  The substance  that is produced by Enterobacteriaceae 
spp. in mixed acid fermentation is stable in non acidic pH. However the 
fermentation reactions lead to pH 6 or below due to accumulation of acids. Gas 
forming microorganism like E.coli, will form an enzyme formic hydrogenylase. 
Formic acid is converted into carbon dioxide and hydrogen by Formic 
hydrogenylase. The result of mixed acid fermentation is production of  
hydrogen. None of the  other 5 pathways listed above  would give rise to 
hydrogen gas as the end product. Gas composition of a gas bubble tends to 
equilibrate naturally with the surrounding tissue, hence it is reasonable that the 
gas will contain reasonable amounts of nitrogen, as well as oxygen, carbon 
dioxide and hydrogen. Trace amounts of ammonia and methane might arise 
from the fermentation of mixed amino acids that were produced by the 
degradation of the necrotic tissue14. 
The mechanism of gas formation is proposed to be  due to various causes 
like  increased gas formation, delay in clearance of gas by vascular compromise, 
gas chamber formation,  and the expansion or collapse of the gas chamber. 
Factors that may be involved in the pathogenesis of EPN are four in 
number namely gas forming bacteria, high tissue glucose levels, impaired tissue 
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perfusion, and a defective immune response. Hyperglycemia is the cause in 
diabetes mellitus14,17,18. The unrelieved obstruction in case of urinary tract 
because of back pressure and impaired circulation, results in decreased 
transportation of gas and subsequent creation of a gas chamber(ie, EPN)8.  
 
Local tissue damage would markedly interferes with clearance of end 
products away from the lesion and accumulation of gas occurs. In the non-
diabetic also, glucose may serve as the substrate for gas formation. In normal 
non-diabetics, around 20 mg% of glucose may be present and up to 60 mg% 
with acute or chronic renal disease. It is said subclinical glucosuria in renal 
infection may some times be enough to generate sufficient amounts of gas [12 
to 36 cc of gas from 100 mg glucose at S.T.P] 2.  
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Fig 1 : Pathogenesis behind emphysematous urinary tract infection14 
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PATHOLOGY 
 
1. Features of inflammation of pelvis and parenchyma,  
2. Abscesses in cortical region of kidney   
3. papillary necrosis.  
4. changes due to decreased  tissue circulation – infarction, thrombosis of 
vessels, arteriosclerosis and glomerulosclerosis. 
5. Infiltration of cells associated with inflammation, focal necrosis and 
abscess formation. 
6. Kimmelstiel-Wilson nodules, hyalinized arteriosclerosis and 
glomerulosclerosis – which are features of diabetic nephropathy. 
              The inflammatory findings are limited to the kidney in class 2 EPN,  in 
extensive involvement  extension  to the perinephric areas in seen. 
CLASSIFICATION  
 
Huang et al Classification. 
 
Class 1 – Gas in the collecting system only (Emphysematous pyelitis) 
Class 2 – Gas in the renal parenchyma without extension into the extrarenal 
space 
Class 3A- Extension of gas or abscess to the perinephric space 
Class 3B- Extension of gas or abscess to the pararenal space 
Class 4 – Bilateral EPN/Solitary kidney with EPN 8 
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Wan et al 
 
Type I 
 
Renal necrosis with either the presence of a streaky/mottled gas pattern 
demonstrated on radiograph or total absence of fluid content on CT or CT with 
lung window display. 
Type II 
Characterized either by the presence of gas in the collecting system or the 
presence of renal/perirenal fluid in association with a bubbly/loculated gas 
pattern.  
Type I emphysematous pyelonephritis is associated with more extensive 
parenchymal necrosis and a more fulminating clinical course than type II 7  
 
Mitra et al also divided renal emphysema into two distinct entities and 
proposed  to have important prognostic and therapeutic implications. 
1. Emphysematous pyelitis : A milder form is characterised by  gas in the 
pelvicalyceal system. It is associated with obstructive uropathy6,19.  
2. Emphysematous pyelonephritis : Gas in this type  extends in addition 
to renal pelvis, calyx, parenchyma, tissues around kidney and 
retroperitoneum   15. 
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Michaeli et al classification 
Stage I - Gas within the renal parenchyma or in the perinephric tissues. 
Stage II -  Presence of gas in the kidney and its surrounding tissues. 
Stage III - Extension of gas through fascia of kidney or Involvement  of 
bilateral EPN. 
CLINICAL PRESENTATION 
EPN presents commonly in adults 20.Juvenile diabetics is not a risk factor.  
Men are less affected than women 21. The  patient presents with features of 
pyelonephritis that fails to resolve during the first 3 days of treatment. Chronic 
infection preceding  an acute attack is also seen in some cases.  Almost all 
patients present with any two of  the classic triad of fever, vomiting and flank 
pain and pyuria.16. May also show symptoms non-specific, such as pain in the 
abdomen, nausea, vomiting and  altered sensorium. It accompanies shock, 
lumbar tenderness, dysuria, crackling feel in the flanks, and  
pneumaturia. [2],[3],[4],[6],[9] When infection involves the collecting system 
pneumaturia is present. Culture test of urine are invariably positive. 
Most often organism identified is E.coli; Klebsiella and Proteus are less 
common. Huang et al founded  fever in 79%, nausea/vomiting in 17%,  shock in 
29%, alteration in conscious level in 19% and acute renal functional impairment 
in 35% of cases 8. 
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               Michaeli, in his study of 55 patients found chills, fever(57%) , flank 
pain(46%) , Lethargy and confusion(22%) , Nausea preceding  vomiting (14%), 
shock and coma(14%) . Pyrexia of unknown origin was the presenting feature in 
some 18%. Pneumaturia is uncommon. The average duration of all these 
symptoms  was 21 days- the range being 0.5 to 240 days before diagnosis 6.                                                   
Diabetes has higher incidence in EPN - 80% (Shokeir et al 12), 96% 
(Huang et al 8), and 87% (Michaeli et al 6).25 The preferable side of involvement 
was predominantly left (60% in Shokeir et al’s study12 and 47% (Bum Soo Park 
et al)5. Affection of both kidneys also ranged from 5% 12 to 20%22. The clinical 
sign is costovertebral angle tenderness5. Leukocytosis present in about 67% and 
thrombocytopenia is seen in 46%8. Patients may present in  medical emergency 
casuality viz., diabetic ketoacidosis. 
 
MICROBIOLOGY 
                
The commonest  reported organism  is E. Coli (69% to 73%) followed by 
Klebsiella (27%)8,6. Blood stream involvement by bacteria  is found in almost 
50% of all the cases and usually the organisms that are grown in urine , blood 
and tissue cultures matches it 8,12. 19% of cases show more than one organism6. 
RADIOLOGY 
The definitive mode of diagnosis of EPN is by radiology. Radiology 
helps to confirm the presence of EPN and classify EPN hence guiding the 
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treatment  and assessment of prognosis of the disease. It is investigated  by X-
ray, USG and CT scan. Best early pick up rate is by CT. Extent of gas 
dissemination is defined with great accuracy. It stages the gas distribution and 
facilitates  description of the gas in the renal system as streaky, mottled, bubbly, 
rim like, crescent shaped, locular, etc. CT helps in diagnosis and follow up. It 
picks up the development of new lesions as well, resolution of the gas and 
abscesses.  
The USG, though not sensitive in identifying renal gas helps in diagnosis 
obstruction of urinary tract. Intraparenchymal gas is shown as strong focal 
echoes23,24. 8 The “dirty” white shadows is diagnostic whereas “clean” 
shadowing is due to calculus. USG is cheap, readily available and non invasive.  
Plain X-ray of the KUB region shows  gas distribution  in the renal and  
perirenal areas in 33% of cases. One may differentiate  renal gas from overlying 
intestinal gas in equivocal cases  by Infusion nephrotomography 6. Differential 
diagnosis of gas in EPN is traumatic renal infarction 
IVU [Intravenous urogram] demonstrates absence of excretion of kidney 
in 27 around 45%. Even those who showed excretion, had  poor delineation. 
Due to the toxic side effects of contrast in  IVU on the kidneys in diabetics and 
as not much information is provided by it  because of non functioning or poorly 
functioning system on affected side, its use should be weighed judiciously 
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compared to plain CT. IVU  shows gas and other findings such as areas of renal 
inflammation like indistinct margins and mass effect12. 
Obstruction is demonstrated in around 25% of cases 21 and is better 
demonstrated by USG or retrograde pyelogram. 3 main patterns of findings on 
X-rays described by Langston and Pfister had an apparent similarity with the 
stage of the disease. Earliest sign is diffuse mottled appearance of the renal 
parenchyma, with radial distribution of the gas bubbles either along the 
pyramids or within the tubules. Bubbly parenchyma with crescent of gas 
denotes further clinical deterioration. With extension through the Gerota’s 
fascia, gas can be seen in the retroperitoneum and may even extend upto the 
posterior thoracic wall25. 
Bum Soo Park et al found plain Xray KUB as reliable modality of 
screening investigation (picked up 50% of cases) and CT as the most reliable 
modality for diagnosis  confirmation (Diagnostic rate 100%) for planning 
treatment. According to him USG unhelpful to locate renal gas5. 
MANAGEMENT 
All patients invariably needs supportive resuscitative measures as patient 
is acutely ill. Intensive measures aimed at glycaemic control by insulin , 
maintenance of fluid balance by serial electrolyte level monitoring and 
treatment of shock  as quickly as possible. Antibiotics can be changed later 
according to sensitivity once culture results are available but beforehand 
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empirical antibiotic is started immediately. Obstruction, if present, should be 
relieved urgently. 
Joseph.B.Stokes JR26, Dunn and Dewolf et al, in their study of 3 cases 
treated by nephrectomy27 favoured an initial trial of conservative management 
with antibiotics.  According to Schultz and Klorfein, the disease is best 
managed by intensive medical methods of treatment and is not an indication of 
emergency surgery. They found that involvement of contralateral kidney was 
often present and really nephrectomy is unwarranted2. Their main concern was 
the probability of  recurrent disease in the contralateral kidney. 
Nephrectomy could be considered if the renal and perirenal gas or the 
toxic symptoms persists inspite of conservative management.  Such patients 
may even be started on lifelong suppressive antibiotics and be followed up 
strictly instead of nephrectomy. Medical management of EPN  is preferable 
because of high chances of involvement of opposite kidney due to disease 
recurrence as well as diabetic disease. Avoidance of surgery, vigorous blood 
sugar control, appropriate antibiotics and relief of obstruction was rational. 
Previous days treatment ideas were that mere medical treatment does not 
decrease mortality or morbidity hence supplemented by prompt surgical 
drainage and nephrectomy. Renal conservation has come into vogue for reasons 
already mentioned. The need to save the kidney in the setting of a high 
probability of the disease occuring in the opposite side later as well as the long 
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term effects of diabetes on the opposite kidney. In conditions like synchronous 
bilateral disease as well as EPN affecting a solitary kidney this modality of 
minimal invasive procedures with renal conservation is highly desirable. 
The importance of perinephric extension of gas was insisted by Huang            
et al8. Even though the differences in clinical presentation is not that much 
different between classes, mortality and failure of PCD tends to increase from 
class 1 to 4. The best prognosis was enjoyed by class 1 patients. PCD and 
antibiotics with relief of obstruction keeps these patients recovering. 
In class 2 also, all patients treated so, were shown recovery. In class 3 and 
4 morbidity is based on the presence of risk factors. Presence of less than two 
risk factors response increased when subjected to PCD and antibiotic. 85% of 
patients with <2 risk factors (reduced platelet count, decreased renal function, 
alteration in consciousness and low blood pressure)  show renal conservation. 
The failure rate of conservative treatment (i.e., combined medical and 
minimally invasive treatment) was less for those with no or single factor 
example 15% for those with no or a single risk factor and 92% for those with 2 
or more risk factors. In such cases, nephrectomy is expected to give the best 
management outcome. The usefulness of PCD is it drains the pus, releases the 
gas and thereby  the pressure to local circulation is relieved and improves 
circulation, provides pus that can be cultured and can help in further 
management and can promote  increased rates of success in extensive EPN. 
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They suggest PCD and antibiotics less extensive disease (class 1 & 2) and also 
for extensive EPN with < 2 risk factors. This leads to a renal conservation in 
most of the cases. 
Nephrectomy provided the best treatment outcome for extensive EPN 
with fulminant course (2 or more risk factors). Even in class IV drainage of gas 
is attempted first. Emergency nephrectomy in such individuals carries poor 
prognosis and increased mortality. Nephrectomy should be done if PCD fails. 
Prognostic factor do not include poor glycemic control. Multiple organ 
dysfunction in EPN affects outcome of treatment as disease runs a rapid 
progression with poor outcome. Severe proteinuria also carried poor outcome 
and seemed to be involved in extensive disease. The causes of severe 
proteinuria may be multifactorial with fever underlying glomerulonephritis, and 
diabetic nephropathy may contribute. 
Michaeli et al6, in their review, is of the opinion that renal conservation 
were often not successful whereas bilateral surgery was successful at times. 
Thus  most important factor associated with survival was an approach 
combining medical and surgical treatment. The observation is the most 
favourable outlook of minimally invasive surgery was for individuals with non 
obstructive unilateral disease and short interval of symptoms of EPN.  
Wan et al described two classes of EPN7. The dry type (type 1) which is  
associated with parenchyma destruction, absence of fluid collection and streaky 
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or mottled gas presented a fulminant course with a mortality rate of 66%. Type 
2 is associated with a mortality rate of 18%. This difference in observation is  
due to compromise in immunity and vascular insufficiency in the kidneys and 
immunocompromise  in the diabetics. They described serum creatinine > 
1.4mg% was associated with a poor outcome. 
In their study of 20 cases, Shokeir et al12 is in for nephrectomy which is 
scheduled  immediately follow aggressive resuscitation and diabetes control.                  
Stein et al, in their case report and review of literature22, insisted on treatment of 
bilateral disease in multiple ways and combination. Endoscopic stenting, PCD 
bilaterally / unilaterally which includes PCN both sides or single side depending 
on extensive involvement and stenting.  Nephrectomy ipsilateal and open 
drainage decided according to progress. 
 
Few others also considered nephrectomy to be the most effective 
modality of treating EPN as evidenced by Bum Soo Park et al5 . They were for 
concomitant immediate nephrectomy and all supportive and resuscitative 
measures. Renal conservation (with PCD and antibiotics) were aimed in solitary 
kidney, poor general/medical condition rendering the patient unfit for surgery, 
inadequate function of other kidney and disease of bilateral kidney.  
Nephrectomy is done through 11th rib bed approach through the loin. 
Hung et al 29 have noted anaerobic bacteria, B. fragilis as the  causative 
organism in a case of EPN. According to him anaerobes are never a causative 
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pathogen rarely one case has been reported with clostridium30. Anaerobes also 
cause hence anaerobic treatment is needed. 
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MATERIALS AND METHODS 
 
Study group:  Patient who were admitted in Kilpauk Medical College and 
Government Royapettah Hospital with Emphysematous Pyelonephritis were 
included in the study. 
Study design: Prospective clinical study 
Materials: Patients who had features of emphysematous pyelonephritis were 
admitted, investigated and descriptive study made with relation to age, sex, 
diabetic status, level of consciousness, shock, biochemical parameters, imaging 
studies and subjected for conservative and minimally invasive modalities of 
treatment. Results were analysed risk factors which led to invasive treatment 
were also analysed 
Study period: 2 years from December 2012 to November 2014 
Inclusion criteria 
1. Patients with features of acute pyelonephritis with gas in the renal 
parenchyma and perinephric and paranephric tissues. The symptoms were 
Fever, chills, loin pain, altered sensorium and vomiting. 
2. Patients admitted in the emergency, but subsequently evaluated and found 
to have gas in the renal parenchyma and beyond it with features of acute 
pyelonephritis 
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Exclusion criteria 
1. Patients with clinical features suggestive of acute pyelonephritis without 
gas in the renal parenchyma. 
2. Presence of history of recent endoscopic or open interventions in the 
urinary tract. 
3. Recent catheterization history. 
 
24 
 
 
 
 
Fig 2: Protocols of Management 
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All patients who had symptoms of  fever, loin pain and vomiting, altered 
sensorium underwent preliminary Xray KUB and USG abdomen. If findings 
suspicious of gas were present, they are subjected for CT scan for confirmation 
and basic staging of class (with contrast enhancement if the renal parameters 
were not raised). Patients in whom gas could not be noticed  in either of these 
investigation  also underwent CT scan based on clinical examination and 
suspicion due to clinical features of acute toxic illness. The patients were 
stratified based on Huang et al’s CT classification8. 
On admission, baseline history recorded which included age, sex, history, 
duration of  symptoms and diabetic mellitus status, its duration, modality  and  
regularity of treatment. The clinical features recorded to know whether 
symptoms and signs have got significance in assessing outcomes of minimally 
invasive interventions in management of EPN. Signs included hemodynamic 
status, presence of shock if any, the degree of consciousness, hydration status 
abdominal distension and mass if any.  Basic Investigations like urine culture, 
blood culture, blood glucose level, serum creatinine, blood urea, total and 
differential WBC counts, blood haemoglobin level, urine acetone  and serum 
electrolytes when there is raise in renal parameters were recorded on admission. 
A blood platelet count was done. 
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Shock was defined as systolic BP <90 mm Hg. Raised renal  parameter 
was defined as increased if serum creatinine > 1.5 mg% or blood urea >40mg%. 
Altered consciousness was defined as patient in confusion, delirium, stupor or 
coma. 
All admitted  patients were given resuscitative measures to correct 
hydration, urosepsis and relief of obstruction. Antibiotic  chosen for  all patients 
belong to  3rd generation cephalosporins (cefotaxime, ceftriaxone or 
cefoperazone), piperacillin tazobactum and metrogyl. Aminoglycosides may be 
added  after looking into renal parameters if  normal. Antibiotics were later 
changed if necessary, based on culture and sensitivity. Intensive resuscitation 
was carried out with hydration, correction of electrolyte imbalance if any and 
measures to treat  diabetes was initiated with insulin. 
Initially  patients are subjected to undergo conservative management with 
only antibiotics, antibiotics with PCD &/or DJ stenting. PCD was defined as 
percutaneous aspiration/ drainage of pus and gas with/without percutaneous 
nephrostomy. PCN/ PCD was done usually under USG guidance using a 8.5Fr 
single puncture PCN catheter in prone, prone oblique or lateral positions via the 
flank taking strict aseptic care  to avoid contamination of the peritoneum. 
Failure of minimal invasive treatment is continuing symptoms and signs with 
persistence of gas in radiological images.  Duration of time to recovery from 
acute illness recorded for all patients. Assessment of response done by CT, USG 
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and serial measurement of platelet count, total count, blood urea, serum 
creatinine and if on PCN,  PCN fluid analysis. Our patients, were stratified 
depending on outcome, as “good” and “poor” outcome . The “good” outcome is 
those treated with antibiotics only or PCD +/_ DJ stenting or DJ stenting only 
with antibiotics. The “poor” outcome  is who failed to respond to minimal 
invasive treatment  and needs invasive open drainage/nephrectomy to prevent 
mortality. 
Statistical analysis:  
Descriptive statistics was done for all data and suitable statistical tests of 
comparison were done. Continuous variables were analysed with the Unpaired t 
test and categorical variables were analysed with Fisher Exact Test. Statistical 
significance was taken as P < 0.05. The data was analysed using EpiInfo 
software (7.1.0.6 version; Center for disease control, USA) and Microsoft Excel 
2010. 
Sample size calculation 
Sample size was determined based on  
Study  
Emphysematous pyelonephritis: Our experience with conservative 
management in 14 cases 
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Authored by 
Pramod Kumar Sharma, Ritu Sharma, 1 Mukesh K. Vijay, Punit 
Tiwari, Amit Goel, and Anup K. Kundu 
Published in 
Urol Ann. 2013 Jul-Sep; 5(3): 157–162. 
In this study two (14%) had thrombocytopenia while seven had deranged 
renal parameters at the time of admission 
Description: 
• The confidence level is estimated at 95% 
• with a z value of 1.96 
• the confidence interval or margin of error is estimated at +/-12 
• Assuming that the sample will have the specified attribute p% =14 and q%=86 
n = p% x q% x [z/e%] ² 
n= 14 x 86 x [1.96/12]² 
n= 32.12 
Therefore 32 is the minimum sample size required for the study 
In our study we have taken 40 as the sample size  
(n=636 in good outcome Group and n=4 in bad outcome Group) 
 
  
 
 
RESULTS 
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RESULTS 
 
Sample size: 
Total number of patients included in this study was 40. 
Age: 
The mean age was 55.02 yrs with a standard deviation of 7.76. Age was 
not significantly related to the outcomes in our study (p=0.48474)  since p>0.05 
Fig :1 
 
 
 
 
 
 
 
Figure 1: Age distribution 
Age Good Outcome % Poor Outcome % 
31-40 Years 1 2.78 0 0.00 
41-50 Years 9 25.00 0 0.00 
51-60 Years 17 47.22 0 0.00 
61-70 Years 8 22.22 3 75.00 
71-80 Years 1 2.78 1 25.00 
Total 36 100 4 100.00 
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Age Good Outcome Poor Outcome 
N 36 4 
Mean 55.02778 66.75 
SD 7.766176 7.675719 
P value 
Unpaired t test 0.48474 
Male 
Sex: 
25% of the total cases were males and 75% were females. Age and Sex 
distribution are not statistically significant, it means that there is no difference 
between the Outcome groups.  
In other words the groups contain subjects with the same basic 
demographic characteristics. (p=0.5558) Fig: 2 
 
 
 
 
 
 
 
Figure 2: Sex distribution 
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Sex Good Outcome % Poor Outcome % 
Male 10 27.78 0 0.00 
Female 26 72.22 4 100.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.5558 
 
Frequency of side affected: 
The left kidney was affected in 52.50% of the cases, the right kidney in 
40% of the cases and both kidneys in 7.50% cases.  
By conventional criteria the association between Sides affected and Outcome 
groups not statistically significant since p > 0.05 (p=0.2057) (Fig 3).  
 
 
 
 
 
 
 
Figure 3: Frequency of side affected 
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Side 
Affected 
Good 
Outcome % Poor Outcome % 
Left 19 52.78 2 50.00 
Right 16 44.44 1 25.00 
Bilateral 1 2.78 1 25.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.2057 
 
Associated Diabetes mellitus: 
87.5% of the patients were diabetic of which 8.5% were newly 
detected.12.5% of the patients were non diabetic.  
By conventional criteria the association between Diabetic status and 
Outcome is not statistically significant since p > 0.05  (p=0.9999) (Fig 4). 
  
 
 
 
 
 
 
Figure 4: Diabetic status 
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Diabetic Status Good Outcome % 
Poor 
Outcome % 
Non Diabetic 5 13.89 0 0.00 
Diabetic 28 77.78 4 100.00 
Diabetic-Recently 
Detected 3 8.33 0 0.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.9999 
 
Treatment of Diabetes mellitus: 
Of the diabetics, 65% were on regular treatment, 25% of whom no 
treatment status available and  5% of patients were on irregular treatment.  
By conventional criteria the association between Diabetes treatment and 
Outcome  is not statistically significant (p=0.6446) (Fig5).  
 
 
 
 
 
 
 
Figure 5: Diabetes treatment 
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Diabetes 
Treatment 
Good 
Outcome % 
Poor 
Outcome % 
Regular 26 72.22 4 100.00 
Irregular 2 5.56 0 0.00 
Unknown 8 22.22 0 0.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.6446 
 
Mode of treatment of Diabetes Mellitus: 
65% were on regular treatment, of which 65% were on OHAs and 5% 
were on insulin.  
By conventional criteria the association between Diabetic mode of 
treatment and outcome  is considered statistically significant as p > 0.05 
(p=0.6415) Fig :6 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Mode of Treatment of DM 
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Diabetes - Mode of 
Treatment 
Good 
Outcome % 
Poor 
Outcome % 
No Treatment 10 27.78 0 0.00 
Oral Hypoglycaemic 
Agents 24 66.67 4 100.00 
Insulin 2 5.56 0 0.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.6415 
 
Duration of treatment of diabetes: 
Duration of diabetic treatment preceding occurrence of Emphysematous 
Pyelonephritis does not show significance with outcome of the disease.  
By conventional criteria the association between Diabetes duration of 
treatment and Outcome groups is considered not significant  (p=0.05836) Fig :7. 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Duration of Treatment of DM 
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Diabetes - 
Duration of 
Treatment(In 
Years) 
Good 
Outcome % 
Poor 
Outcome % 
No Treatment 10 27.78 0 0.00 
1 to 5 5 13.89 0 0.00 
6 to 10 11 30.56 2 50.00 
11 to 15 8 22.22 0 0.00 
> 15 2 5.56 2 50.00 
Total 36 100 4 100.00 
 
Diabetes - Duration of 
Treatment(In Years) Good Outcome Poor Outcome 
N 36 4 
Mean 7.083333 14 
SD 5.827889 4.898979 
P value 
Unpaired t test  0.05836 
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Symptoms: 
The most common mode of presentation was fever & loin pain (26/40 ; 
65%).Loin pain was the only presentation in 30% (12/40) Other modes of 
presentations like seizures, altered sensorium or vomiting constituted the rest 
(5%). Fig: 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Patient complaints 
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Patient Complaints Good Outcome % Poor Outcome % 
Loin Pain+Fever 24 66.67 2 50.00 
Loin Pain 12 33.33 0 0.00 
Altered Sensorium 0 0.00 2 50.00 
Total 36 100 4 100.00 
 
Duration of complaints: 
Duration of complaints is short for poor outcome compared to good 
outcome. Mean duration is 11.52+/- 3.45 days for good outcome and mean 
duration for poor outcome is 6.25+/-  3.75 
 
 
 
 
 
 
 
 
Duration of 
Complaints 
Good 
Outcome % 
Poor 
Outcome % 
Nil 1 2.78 0 0.00 
1 to 5 Days 0 0.00 2 50.00 
5 to 10 Days 13 36.11 2 50.00 
11 to 15 Days 20 55.56 0 0.00 
16 to 20 Days 2 5.56 0 0.00 
Total 36 100 4 100.00 
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Duration of Complaints Good Outcome Poor Outcome 
N 36 4 
Mean 11.52778 6.25 
SD 3.451593 2.753785 
P value 
Unpaired t test  0.02286* 
 
Findings on Clinical Examination:  
On clinical examination, the commonest finding was loin tenderness 
(75%), 20% presented with an abdominal mass and 5% with abdominal 
distension. Fig :9 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Clinical Examination 
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Clinical Examination 
Findings 
Good 
Outcome % 
Poor 
Outcome % 
Loin Tenderness 30 83.33 0 0.00 
Abdominal Mass 6 16.67 2 50.00 
Abdominal 
Distension 0 0.00 2 50.00 
Total 36 100 4 100.00 
 
 
Serum Creatinine: 
20 out of 40 patients (50%) had raised renal parameters. The rest (50%) 
had normal renal parameters. The relationship of serum creatinine value with 
the outcome reached statistical significance (p=0.001902 ) (Fig 10) 
 
 
(13 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Serum Creatinine 
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Baseline 
Serum 
Creatinine 
Good 
Outcome % 
Poor 
Outcome % 
≤ 1.5 U/L 20 55.56 0 0.00 
1.6-2.5 U/L 15 41.67 0 0.00 
2.6-3.5 U/L 0 0.00 2 50.00 
3.6-4.5 U/L 1 2.78 2 50.00 
Total 36 100 4 100.00 
 
 
Baseline Serum 
Creatinine Good Outcome Poor Outcome 
N 36 4 
Mean 1.447222 3.625 
SD 0.585777 0.485627 
P value 
Unpaired t test 0.001092* 
 
By conventional criteria the association between Baseline Serum 
Creatinine levels and outcome  is considered to be statistically significant since 
p < 0.05. 
Statistical Significance 
This indicates that there is a true difference among groups and the 
difference is significant. In simple terms, when studying the Role of minimally 
invasive approaches for renal salvagibility in management of  Emphysematous 
Pyelonephritis, the average serum creatinine levels in good outcome (1.48 U/L) 
is  predominantly less when compared to bad outcome (3.63 U/L).  It is 
statistically significant with a p-value of 0.001092 according to unpaired t test. 
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Clinical Significance 
The average serum creatinine levels in good outcome group are 
meaningfully less than bad outcome group by 2.5 times with a mean difference 
of 2.18 U/L. Similarly the prevalence of normal serum creatinine levels are 
much more in good outcome group(55.56%) and prevalence of increased serum 
creatinine levels is much more in poor outcome group(100%) 
This difference is true and significant and has not occurred by chance. 
Conclusion  
We conclude that there is meaningfully real increase in risk of developing 
poor outcomes  in persons with increased serum creatinine levels among our 
study subjects.  In short  increased serum creatinine levels correlate with poor 
outcomes in our study subjects.  
Base line Blood Urea  
The blood urea values in the good outcome group was 41.416 +/- 8.6499 
and in the poor outcome group was 99.5 +/- 9.036. The relationship of Blood 
Urea value with the outcome reached statistical significance (p=0.000435)  
(Fig11)  
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Figure 11: Baseline Blood Urea 
Baseline Blood 
Urea 
Good 
Outcome % 
Poor 
Outcome % 
≤40 mg/dl 16 44.44 0 0.00 
41-60 mg/dl 20 55.56 0 0.00 
61-80 mg/dl 0 0.00 0 0.00 
> 80 mg/dl 0 0.00 4 100.00 
Total 36 100 4 100.00 
 
Baseline Blood Urea Good Outcome Poor Outcome 
N 36 4 
Mean 41.41667 99.5 
SD 8.649938 9.036961 
P value 
Unpaired t test 0.000435* 
 
By conventional criteria the association between Baseline Blood Urea 
levels and outcome  is considered to be statistically significant since p < 0.05. 
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Statistical Significance 
This indicates that there is a true difference among groups and the 
difference is significant. In simple terms, when studying the Role of minimally 
invasive approaches for renal salvagibility in management of  Emphysematous 
Pyelonephritis, the average Blood Urea levels in good outcome (41.42 mg/dl) is  
predominantly less when compared to bad outcome (99.5 mg/dl).  It is 
statistically significant with a p-value of 0.000435 according to unpaired t test. 
Clinical Significance 
The average Blood Urea levels in good outcome group are meaningfully 
less than bad outcome  by 2.4 times with a mean difference of 58.08 mg/dl. 
Similarly the prevalence of normal Blood Urea levels are much more in good 
outcome (44.44%) and prevalence of increased Blood Urea levels is much more 
in poor outcome (100%) 
This difference is true and significant and has not occurred by chance. 
Conclusion  
We conclude that there is meaningfully real increase in risk of developing 
poor outcomes  in persons with increased Blood Urea levels among our study 
subjects.  In short increased Blood Urea levels correlate with poor outcomes in 
our study subjects.  
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Shock at presentation: 
9 out of the total 40 patients (22.5%) presented with shock. The  
relationship of shock with the outcome was statistically significant (p=0.0014). 
(Fig 12)  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Shock at presentation 
 
Incidence of 
Shock 
Good 
Outcome % 
Poor 
Outcome % 
Shock - 31 86.11 0 0.00 
Shock + 5 13.89 4 100.00 
0 0 0.00 0 0.00 
0 0 0.00 0 0.00 
0 0 0.00 0 0.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.0014* 
 
By conventional criteria the association between Incidence of Shock and 
Outcome  is considered to be statistically significant since p < 0.05. 
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Statistical Significance 
• In simple terms, the incidence of Shock in Emphysematous 
Pyelonephritis patients is 13.89% in good outcome  compared to 100% in 
bad outcome   with a p-value of 0.0014 according to Fisher’s Exact  test. 
• This indicates that there is a true difference among the study groups and 
the difference is significant and has not occurred by chance. 
Clinical Significance 
• The incidence of Shock in Emphysematous Pyelonephritis patients was 
meaningfully 86.11 percentage points  less  in good outcome  compared 
to bad outcome group 
• In our study subjects incidence of Shock leads to 7.2 times increase in 
occurrence of bad outcomes.  
Conclusion  
We conclude that incidence of Shock is detrimental in nature and can lead 
to an increasing trend of bad outcomes.  
Mental status on presentation: 
92.5% patients presented in normal mental status while 7.5% had altered 
mental status on presentation. Out of 3 patients with altered mental status, 3 
were in the poor outcome. Thus, altered mental status had a statistically 
significant relationship with the outcome( p=0.004). (Fig 13)  
 Figure 13 : Mental status at presentation 
 
Mental Status Good Outcome % Poor Outcome % 
Stable 36 100.00 1 25.00 
Unstable 0 0.00 3 75.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.0004* 
 
                 By conventional criteria the association between mental status and 
Outcome groups is considered to be statistically significant since p < 0.05. 
Statistical Significance 
• In simple terms, the incidence of unstable mental status in 
Emphysematous Pyelonephritis patients is 0% in good outcome group 
compared to 75% in bad outcome group 
• Similarly  the incidence of stable mental status in Emphysematous 
Pyelonephritis patients is 100% in good outcome group compared to 25% 
in bad outcome group with a p-value of 0.0004 according to Fisher’s 
Exact test. 
• This indicates that there is a true difference among the study groups and 
the difference is significant and has not occurred by chance. 
Clinical Significance 
• The incidence of stable mental status in Emphysematous Pyelonephritis 
patients was meaningfully 75.00 percentage points  more  in good 
outcome group compared to bad outcome group 
In our study subjects incidence of stable mental status leads to 4 times increase 
in occurrence of good outcomes.  
Conclusion  
We conclude that incidence of unstable mental status is detrimental in nature 
and can lead to an increasing trend of bad outcomes.  
Blood sugar : 
In the present study, the blood sugar value associated with a good outcome was 
206.444 +/- 39.151 and the value associated with poor outcome was 375.50+/- 
40.553. Blood sugar values at presentation shows  significant correlation 
with the outcome (0.001981) Fig :14. 
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Figure 14: Blood Sugar 
Blood Sugar Good Outcome % 
Poor 
Outcome % 
≤ 200 mg/dl 20 55.56 0 0.00 
201-300 mg/dl 16 44.44 0 0.00 
301-400 mg/dl 0 0.00 4 100.00 
Total 36 100 4 100.00 
 
 
 
 
Blood Sugar Good Outcome Poor Outcome 
N 36 4 
Mean 206.4444 375.5 
SD 39.15131 40.55038 
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DKA at presentation: 
3 patients (7.5%) were in DKA at presentation. No statistically significant 
correlation was found between DKA at presentation and outcome (p=0.273) 
(Fig 15). 
 
 
 
 
 
 
 
Figure 15: Diabetic Ketoacidosis 
 
Diabetic 
ketoacidosis 
Good 
Outcome % 
Poor 
Outcome % 
DKA - 34 94.44 3 75.00 
DKA + 2 5.56 1 25.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.2773 
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Platelet count: 
In the present study, the correlation between platelet counts and outcome 
was significant (p=0.0001). The patients were further stratified into two groups 
based on whether the platelet count was above or below 120000/cu.mm. In the 
below 120000/cu.mm group, 1/5 were associated with a good outcome and 4/5 
were associated with a poor outcome. In the above 120000/cu. mm group, 35/35 
were associated with a good outcome and 0/35 were associated with a poor 
outcome. This reached statistical significance with a p value of 0.0001.Fig: 16 
 
 
 
 
 
 
 
Figure 16: Platelet Count 
Baseline Platelet 
Count 
Good 
Outcome % 
Poor 
Outcome % 
< 1.2 lakh 1 2.78 4 100.00 
> 1.2 lakh 35 97.22 0 0.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.0001* 
 
By conventional criteria the association between Baseline Platelet Count 
and Outcome is considered to be statistically significant since p < 0.05. 
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Statistical Significance 
• In simple terms, the incidence of baseline platelet count < 1.2 lakh  in 
Emphysematous Pyelonephritis patients is 2.78% in good outcome  
compared to 100% in bad outcome  with a p-value of 0.0001 according to 
Fisher’s Exact test. 
• This indicates that there is a true difference among the study groups and 
the difference is significant and has not occurred by chance. 
Clinical Significance 
• The incidence of baseline platelet count < 1.2 lakh  in Emphysematous 
Pyelonephritis patients was meaningfully 97.22 percentage points  less  in 
good outcome  compared to bad outcome  
• In our study subjects incidence of baseline platelet count < 1.2 lakh  leads 
to 36 times increase in occurrence of bad outcomes.  
Conclusion  
We conclude that incidence of baseline platelet count < 1.2 lakh  is 
detrimental in nature and can lead to an increasing trend of bad outcomes.  
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Total count: 
The correlation between blood TC and outcomes was statistically 
significant. When patients were further stratified based on whether their total 
count was above or below 10000/cu.mm. All patients in the below 
10000/cu.mm group were associated with a good outcome. In the above 
10000/cu.mm group, 8/12 were associated with a good outcome and 4/12 were 
associated with poor outcome. This association reached statistical significance 
(p=0.0054) Fig: 17. 
 
 
 
 
 
 
 
Figure 17: Total Count 
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Baseline Total 
count 
Good 
Outcome % 
Poor 
Outcome % 
< 10000 28 77.78 0 0.00 
> 10000 8 22.22 4 100.00 
Total  36 100 4 100.00 
P value 
Fisher’s Exact test 0.0054* 
 
By conventional criteria the association between Baseline Total Count 
and Outcome  is considered to be statistically significant since p < 0.05. 
Statistical Significance 
• In simple terms, the incidence of baseline Total count > 10000  in 
Emphysematous Pyelonephritis patients is 22.22% in good outcome  
compared to 100% in bad outcome with a p-value of 0.0054 according to 
Fisher’s Exact test. 
• This indicates that there is a true difference among the study groups and 
the difference is significant and has not occurred by chance. 
Clinical Significance 
• The incidence of baseline Total count > 10000 in Emphysematous 
Pyelonephritis patients was meaningfully 77.78 percentage points  less  in 
good outcome compared to bad outcome  
• In our study subjects incidence of baseline Total count > 10000 leads to 
4.5 times increase in occurrence of bad outcomes.  
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Conclusion  
We conclude that incidence of baseline Total count > 10000 is 
detrimental in nature and can lead to an increasing trend of bad outcomes.  
Blood Haemoglobin (Hb): 
In the present study, the mean Hb value was 10.75 with a S.D of 0.43. In 
good outcome patients, the Hb was 10.75 +/- 0.433. In the poor outcome, the 
Hb was 8.1500 +/- 1.2909. There was no  statistically significant correlation 
between the Hb value and the outcomes since p>0.05 (p=0.0807 Fig :18  
 
 
 
 
 
 
 
 
Figure 18: Haemoglobin levels 
Haemoglobin 
Levels 
Good 
Outcome % 
Poor 
Outcome % 
< 9 g/dl 0 0.00 2 50.00 
9.1-11 g/dl 26 72.22 2 50.00 
11.1-13 g/dl 10 27.78 0 0.00 
Total 36 100 4 100.00 
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Haemoglobin Levels Good Outcome Poor Outcome 
N 36 4 
Mean 10.75 9.075 
SD 0.433919 1.297112 
P value 
Unpaired t test 0.0807 
 
CT classification: 
The following was the distribution of the patients8. 
Class 1 – 5% (2 patients) 
Class 2 – 52.5% (19 patients) 
Class 3A- 25% (10 patients) 
Class 3B- 15% (6 patients) 
Class 4- 7.5% (3 patients) There was correlation made out between CT class 
and the outcome (p=0.001) (Fig19).  
 
 
 
 
 
 
 
Figure 19: CT classification 
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Baseline CT 
Findings 
Good 
Outcome % 
Poor 
Outcome % 
Stage I 2 5.56 0 0.00 
Stage II 19 52.78 0 0.00 
Stage IIIA 10 27.78 0 0.00 
Stage IIIB 4 11.11 2 50.00 
Stage IV 1 2.78 2 50.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.001* 
 
By conventional criteria the association between CT findings and 
Outcome groups is considered to be statistically significant since p < 0.05. 
Statistical Significance 
• In simple terms, the incidence of CT Stage IV in Emphysematous 
Pyelonephritis patients is 2.78% in good outcome compared to 50% in 
bad outcome with a p-value of 0.001 according to Fisher’s Exact test. 
• This indicates that there is a true difference among the study groups and 
the difference is significant and has not occurred by chance. 
Clinical Significance 
• The incidence of CT Stage IV findings in Emphysematous Pyelonephritis 
patients was meaningfully 47.22 percentage points  less  in good outcome 
group compared to bad outcome group 
• In our study subjects incidence of CT Stage IV finding leads to 18 times 
increase in occurrence of bad outcomes.  
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Conclusion  
We conclude that incidence of CT Stage IV finding in our subjects is 
detrimental in nature and can lead to an increasing trend of bad outcomes.  
Results of urine culture: 
The commonest organism grown in urine culture was E.coli (75%). E.coli 
with Proteus was grown in 5%, and other organisms (Klebsiella, Proteus) in 
20%.Urine culture result did not correlate with the outcome (p=0.644) (Fig 20). 
 
 
 
 
 
 
 
Figure 20: Urine Culture 
 
Urine Culture Good Outcome % 
Poor 
Outcome % 
E. Coli 27 75.00 3 75.00 
Klebsiella 4 11.11 0 0.00 
Proteus 3 8.33 1 25.00 
All 2 5.56 0 0.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.6444 
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Results of blood culture: 
Blood cultures were positive in 15% of the cases. Of the 6 patients with a 
positive blood culture, 4 had poor outcome .The relationship between blood 
culture positivity and outcome reached statistical significance (p=0.0001).              
(Fig 21) 
 
 
 
 
 
 
 
Figure 21: Blood Culture 
 
Blood 
Culture 
Good 
Outcome % Poor Outcome % 
Negative 34 94.44 0 0.00 
Positive 2 5.56 4 100.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.0001* 
 (18 
By conventional criteria the association between Blood Culture findings 
and Outcome is considered to be statistically significant since p < 0.05. 
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Statistical Significance 
• In simple terms, the incidence of Blood Culture Positivity in 
Emphysematous Pyelonephritis patients is 5.56% in good outcome group 
compared to 100% in bad outcome with a p-value of 0.0001 according to 
Fisher’s Exact test. 
• This indicates that there is a true difference among the study groups and 
the difference is significant and has not occurred by chance. 
Clinical Significance 
• The incidence of Blood Culture Positivity in Emphysematous 
Pyelonephritis patients was meaningfully 94.44 percentage points  less  in 
good outcome compared to bad outcome  
• In our study subjects incidence of Blood Culture Positivity leads to 18 
times increase in occurrence of bad outcomes.  
Conclusion  
We conclude that incidence of Blood Culture Positivity finding in our 
subjects is detrimental in nature and can lead to an increasing trend of bad 
outcomes.  
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Presence of obstruction: 
In the present study, urinary tract obstruction was present in 47.5% of 
patients. 52.5% patients did not have associated obstruction. Of the 19 patients 
who had associated urinary tract obstruction, all the 15 were associated with 
good outcome. Of the 21 patients with no associated obstruction, 100% (21/21) 
had a good outcome and 0% (0/21) had a poor outcome. (p=0.0001).This 
implies that presence of obstruction when relieved would assist renal 
conservation. Fig: 22 
 
 
 
 
 
 
 
Figure 22: Presence of Obstruction 
 Presence of 
Obstruction 
Good 
Outcome % 
Poor 
Outcome % 
Obstruction - 21 58.33 0 0.00 
Obstruction + 15 41.67 4 100.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.0001* 
 
By conventional criteria the association between Presence of Obstruction 
and Outcome groups is considered to be statistically significant since p < 0.05. 
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Statistical Significance 
• In simple terms, the incidence of Presence of Obstruction in 
Emphysematous Pyelonephritis patients is 41.67% in good outcome  
compared to 100% in bad outcome  with a p-value of 0.0001 according to 
Fisher’s Exact test. 
• This indicates that there is a true difference among the study groups and 
the difference is significant and has not occurred by chance. 
Clinical Significance 
• The incidence of Blood Culture Positivity in Emphysematous 
Pyelonephritis patients was meaningfully 58.33 percentage points  less  in 
good outcome compared to bad outcome  
• In our study subjects incidence of Blood Culture Positivity leads to 2.4 
times increase in occurrence of bad outcomes.  
Conclusion  
We conclude that incidence of Presence of Obstruction finding in our 
subjects is detrimental in nature and can lead to an increasing trend of bad 
outcomes.  
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Modes of treatment: 
Antibiotics only was used in 10% of patients. DJ stenting was the only 
modality in 65% of the patients and PCD only in 5%. PCD was combined with 
DJ stenting in 15% of patients. Open drainage after PCD and DJ stenting failure 
is 5%. Nephrectomy after PCD failure is 5%. Fig :23 
 
 
 
 
 
 
Figure 23: Modes of Treatment 
Treatment Given Good Outcome % 
Poor 
Outcome % 
Antibiotics 4 11.11 0 0.00 
DJ Stenting 26 72.22 0 0.00 
PCD+DJ Stenting 6 16.67 0 0.00 
PCD+DJ Stenting failed- 
Open Drainage 0 0.00 2 50.00 
PCD failed - Nephrectomy 0 0.00 2 50.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 01774 
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Post conservative treatment Platelet count 
 
 
 
 
 
 
 
Figure: 24 
Post conservative treatment Serum Creatinine 
 
 
 
 
 
 
 
 
Figure: 25 
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Post conservative treatment Total count 
 
 
 
 
 
 
 
Figure: 26 
 
Risk factors: 
 
 
 
 
 
 
Figure: 27 
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Type of outcome: 
90% patients (36/40 ) had a good outcome in the form of renal 
conservation. 10% patients (4/40) had a poor outcome of minimal invasive 
treatment had renal conservation in form of open drainage - 2/4 and renal loss 
by nephrectomy - 2/4 (Fig 28). 
 
 
 
 
Figure 28: Type of Outcome 
 
 
Further 
Treatment 
Good 
Outcome % 
Poor 
Outcome % 
Continued 36 100.00 0 0.00 
Open Drainage 0 0.00 2 50.00 
Nephrectomy 0 0.00 2 50.00 
Total 36 100 4 100.00 
P value 
Fisher’s Exact test 0.0001* 
 
Poor 
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By conventional criteria the association between Treatment Given and 
Outcome  is considered to be statistically significant since p < 0.05. 
Statistical Significance 
• The incidence of minimally invasive treatment given in Emphysematous 
Pyelonephritis patients is 100% in good outcome  compared to 0% in bad 
outcome .  
• The incidence of invasive treatment given in Emphysematous 
Pyelonephritis patients is 0% in good outcome  compared to 100% in bad 
outcome group with a p-value of 0.0001 according to Fisher’s Exact test. 
• This indicates that there is a true difference among the study groups and 
the difference is significant and has not occurred by chance. 
Clinical Significance 
• The incidence of minimally invasive treatment given in Emphysematous 
Pyelonephritis patients was meaningfully 100  percentage points  less  in 
good outcome  compared to bad outcome  
• In our study subjects incidence of minimally invasive treatment given 
leads to 100 times increase in occurrence of bad outcomes.  
Conclusion:  
We conclude that incidence of minimally invasive treatment given 
correlates with an increasing trend of good outcomes.  
  
 
 
DISCUSSION 
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DISCUSSION 
 
40  patients were included prospectively during the study period. 
Comparison made with the results of the present study with other studies. 
 
Sl. 
No 
 Study   Design Sample  Finding  
1. Huang et al8 Prospective 48 
Class 1 or 2 & class 3 or 4 with <2 
risk 
factors-conservation 
Others-nephrectomy 
2. Michaeli et al6 Retrospective 54 
Resuscitation, early antibiotics, 
relief of 
obstruction & early nephrectomy. 
3. Shokeir et al12 Retrospective 20 Nephrectomy 
4. 
Bum Soo Park 
Et al5 
Retrospective 17 Conservation in selected cases 
5. Chen et al23 Retrospective 25 
Antibiotics with CT guided 
drainage 
6. Wan et al 19 Retrospective 38 
Predictors of high risk – 
S.Creatinine & 
Platelet count 
7. Present study prospective 40 
Minimal invasive surgeries 
feasible. 
Predictors of poor outcome 
identified. 
 
 
Fig 29: Comparative study 
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Age: Mean age in the present study is 55.12 yrs which is comparable with other 
studies 3,5, 6, 7, 8, 12 . 
Sex distribution: In our study, there was a female predominance, which is seen 
in other studies also. 
Side of involvement: In the present study, there was a predominance of left 
over the right side. In other studies also, a similar female predominance is seen. 
Presenting complaints: The predominant mode of presentation in the present 
study was fever associated with loin pain. This is similar to other studies.8,12. 
Duration of symptoms before presentation: 
The mean duration of symptoms before presentation was 11.52 days in 
our study. In Chen et al’s study 3, it was 18 +/- 8.64 days3. In our study, the 
mean duration of symptoms before presentation in the good outcome  was 11.52 
days and in the poor outcome  was 6.25 days. In comparison, in Huang et al’s 
study, the duration of symptoms prior to diagnosis in the good outcome  was 8.2 
days and in the poor outcome  was 6.1 days 8. 
Presence of Diabetes mellitus: 
DM was present in 87.5% of patients in our study which correlates well 
with the studies of Chen et al 3 and Shokeir et al 12.The prevalence of DM in 
Huang et al’s study was 96% 8. 
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Presence of shock: 
In the present study,5/8 (100%) of the patients in poor outcome  presented 
with shock and  (13.89%) of the patients in good outcome  presented with 
shock. In comparison, in Huang et al’s study 56% in the poor outcome  and 
17% of patients in the good outcome  presented with shock 8. 
Altered mental status at presentation: 
In the present study, 3/8 (75.0%) of the patients in poor outcome  
presented with altered mental status and 0/36 (0%) of the patients in good 
outcome  presented with altered mental status. In comparison, in Huang et al’s 
study 50% in the poor outcome  and 3% of patients in the good outcome  
presented with altered mental status8. 
Altered renal parameters: 
In the present study, the mean serum creatinine in patients with good 
outcome was 1.44+/-0.585. The mean serum creatinine in patients with poor 
outcome was3.625+/- 0.485.This reached statistical significance (p=0.040). 
Then the patients were stratified based on a cut off of serum creatinine 
(1.5mg/dl) and patients analysed with regards to the outcome. In the <1.5mg/dl 
group, 20/20 patients fell under the good outcome and 0/20 patients fell under 
the poor outcome. In the >1.5mg/dl group, 16/20 fell under the good outcome 
and 4/20 patients fell under the poor outcome . This was statistically significant 
(p=0.001092). 
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Management and outcome according to radiological classes:  
In the present study, 100% of patients in class 1(2/2) had a good outcome 
which is comparable with the Huang et al study8.In class 2, 100% 
patients(19/19) had a good outcome. This is comparable with the Huang et al 
study8. In class 3A, 100% patients (10/10) had a good outcome and 0% patients 
(0/10) had a poor outcome. In comparison, in the Huang et al study8, there was a 
100% good outcome. In class 3B, 0% patients (4/6) had a good outcome and 
33.33% patients(2/6) had a poor outcome. In comparison, in the Huang et al 
study8, there was a 49% poor outcome. In class 4, 0% patients (1/3) had a good 
outcome and 66.66% patients(2/3) had a poor outcome. In comparison, in the 
Huang et al study8, there was a 75% poor outcome. 
Management and outcome 
In the present study, use of antibiotics only was associated with a good 
outcome in 100% and a poor outcome in 0% patients, while in Huang et al’s 
study, it was associated in 60% and 0% with good and poor outcomes 
respectively8. The use of PCD only was associated with a good outcome in 0% 
and a poor outcome in 100% patients, while in Huang et al’s study, it was 
associated in 66% and 20% with good and poor outcomes respectively8. In the 
present study, PCD with DJ stenting was associated with a good outcome in 
75% and a poor outcome in 25% patients. In patients treated with DJ stenting 
only, there was a 100% successful outcome. 
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Urine cultures: 
In the present study,  E.coli was grown in 75% of patients and combined 
in 5% and either proteus/Klebsiella pneumoniae in 20% of patients. In 
comparison, in the study of Bum Soo Park et al, 52% grew E.coli and 24% grew 
Klebsiella pneumoniae. In their study, 24% did not show any growth in the 
urine5. 
Blood cultures: 
In the present study, blood cultures were positive in 15% of patients. This 
compares well with Wan et al’s study7 in which 42.10% had positive blood 
cultures but is much less than in Bum Soo Park et al’s study5 in which 59% had 
positive blood cultures. 
Obstruction: 
In the present study, obstruction was present in 47.5% of patients. In this 
group, when obstruction was relieved, there was a 78% association with good 
outcome. In the good outcome, 41.75% patients had associated obstruction. This 
contrasts with Huang et al’s study in which good outcome was associated with 
obstruction in 25% patients only8. 
Platelet count: 
In the present study, 2.78% of the patients in the good outcome  and 
100% patients in the poor outcome had thrombocytopenia (platelet count < 
120000). This is comparable to the study by Huang et al8, in which, 28% in the 
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good outcome  and 81% in the poor outcome were associated with a platelet 
count of < 120000. This relationship reached statistical significance in both the 
present and Huang et al’s study8. 
Total count: 
In the present study, leucocytosis in good outcome group was 22.22% 
and in the poor outcome group was 100%. In comparison, in the study by Wan 
et al7, in both it reached clinical significance 
. 
 
  
 
 
 
SUMMARY 
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SUMMARY 
 
                Of the total 40 patients included in the study the following were 
the findings. 
 
• Incidence of Emphysematous pyelonephritis is more in the females. 
• Left side predominates over the right side in incurrence. 
 
• The most common presenting features were fever and loin pain. 
• Emphysematous pyelonephritis commonly affects the diabetics. 
• Patients can have unrelated clinical features and present in the emergency 
casualty  
 
• CT KUB is more useful in diagnosis than USG and Xray KUB. 
• Urine culture  is predominantly positive – the most common organism 
being E.coli spp. 
 
• The organisms grown in blood culture are the same as in urine cultures. 
• Relief of the obstruction assists renal conservation, when there is an 
associated urinary tract obstruction 
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• Various modalities of treatment  like antibiotics, PCD, DJ stenting either 
alone or in combination make minimal invasive approaches possible in 
renal salvagibility feasible in 95% of patients. 
 
• Clinical factors like shock or altered sensorium at presentation, presense 
or absence of associated urinary tract obstruction, laboratory parameters 
like raised serum creatinine, raised TC, positive blood cultures, reduced 
platelet counts are all significant factors in determining the outcome 
during attempted renal conservation out of minimal invasive 
management. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
CONCLUSION 
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CONCLUSIONS 
 
 
1. Minimal invasive management for renal conservation has a definite role 
in properly selected patients of emphysematous pyelonephritis. 
2. The predicting factors at presentation can alter the conservatively 
managed cases of emphysematous pyelonephritis lean towards 
nephrectomy.  
• Shock 
• Altered mental status 
• Raised serum creatinine 
• Total count >10000/cmm 
• Platelet count < 120000/cmm 
• Positive blood cultures 
• Absence of urinary tract obstruction. 
 
 
 
 
 
 
 
 
 
  
 
 
 
PHOTOGRAPHS 
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PHOTOGRAPHS 
 
 
 
 
 
Fig 30: Xray KUB showing gas in RT renal area 
 
 
 
     
 
 
 
Fig 31: Xray KUB showing gas in Lt renal area 
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Fig 32: USG KUB – dirty white shadow 
 
 
 
 
 
 
Fig 33: CT KUB Class 1 EPN 
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Fig 34: CT KUB Class 3B EPN 
 
 
 
 
 
 
 
Fig 35: CT KUB Class 3A EPN 
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Fig 36: CT KUB - class IV EPN 
 
 
 
 
 
 
FIG 37: CT KUB – CLASS III B EPN 
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Fig 38: Nephrectomy in progress 
 
 
 
 
 
 
 
Fig 39: Open drainage of RT kidney EPN 
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ANNEXURE I
Annexure 2 
PROFORMA 
Name                                                              Date of admission 
IP no                                                               Date of discharge 
Age 
Sex 
Complaints 
Duration of symptoms 
H/O DM (along with duration and treatment) 
Clinical examination 
Level of consciousness    Shock / BP 
Loin Tenderness     Temp: 
Investigations at presentation 
       Blood sugar 
       Serum creatinine & Blood urea 
       Total WBC count &  Haemoglobin 
       Platelet count 
       Urine acetone 
       Urine culture & sensitivity  
       Blood culture 
       Mode of diagnosis 
       CT class 
       Presence of obstruction 
       Treatment category 
       Antibiotics used 
       Post conservative management serum creatinine 
       Post conservative management platelet count 
       Post conservative management recovery of signs and symptoms 
       Post conservative management CT 
       Follow up treatment if any  
       Outcome 
       Number of days of hospital stay 
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